Stocktoria
Jiangsu Hengrui Pharmaceuticals Co.,Ltd 600276.SS
Jiangsu Hengrui Pharmaceuticals Co.,Ltd statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (CN¥15.97); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Jiangsu Hengrui Pharmaceuticals Co.,Ltd trades at about 45.6× earnings — below its 10-year norm (10-year range 44.6×–69.2×, median 55.1×).
Shaded band = 10-year range (44.6×–69.2×); dot = today's 45.6×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 86.2% | 86.2% | 84.6% | 83.6% |
| Operating margin | 27.2% | 24.3% | 20.3% | 15.7% |
| Net margin | 24.4% | 22.6% | 18.9% | 18.4% |
| FCF margin | 26.2% | 19.5% | 27.0% | -3.4% |
| Return on assets | 11.0% | 12.6% | 9.8% | 9.2% |
| Return on equity | 12.6% | 13.9% | 10.6% | 10.3% |
| Current ratio | 8.08 | 9.72 | 12.25 | 8.50 |
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.